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Crystal Structure of Human Cytosolic
Phospholipase A2 Reveals a Novel
Topology and Catalytic Mechanism
trienes (Glover et al., 1995; Schievella et al., 1995). Al-
though these data are compelling, the most definitive
evidence for the central role of cPLA2 in eicosanoid and
PAF production came from mice made deficient in cPLA2
through homologous recombination (Bonventre et al.,
AndreÂ a Dessen,* Jin Tang, Holly Schmidt, Mark Stahl,
James D. Clark, Jasbir Seehra, and William S. Somers*
Biochemistry
Wyeth Research
87 Cambridge Park Drive
Cambridge, Massachusetts 02140 1997; Uozumi et al., 1997). Peritoneal macrophages de-
rived from these animals failed to make leukotrienes,
prostaglandins, or PAF. The cPLA2-deficient mice have
also been informative of the role of cPLA2 in disease,Summary
since these animals are resistant to bronchial hyperreac-
tivity in an anaphylaxis model used to mimic asthmaCytosolic phospholipase A2 initiates the biosynthesis
(Uozumi et al., 1997). Thus, despite the size of the phos-of prostaglandins, leukotrienes, and platelet-activat-
pholipase A2 superfamily, cPLA2 is essential for prosta-ing factor (PAF), mediators of the pathophysiology of
glandin, leukotriene, and PAF production.asthma and arthritis. Here, we report the X-ray crystal
Maximal cPLA2 activation requires sustained phos-structure of human cPLA2 at 2.5 AÊ . cPLA2 consists
phorylation and mobilization of intracellular calcium (Linof an N-terminal calcium-dependent lipid-binding/C2
et al., 1993; Qiu et al., 1998). Calcium activation is medi-domain and a catalytic unit whose topology is distinct
ated by an N-terminal Ca21-dependent lipid-bindingfrom that of other lipases. An unusual Ser-Asp dyad
(CaLB) domain that colocalizes the catalytic domain withlocated in a deep cleft at the center of a predominantly
its membrane substrate (Nalefski et al., 1994). The struc-hydrophobic funnel selectively cleaves arachidonyl
ture of the CaLB domain has been solved (Perisic et al.,phospholipids. The structure reveals a flexible lid that
1998; Xu et al., 1998), and it is a member of the C2 family;must move to allow substrate access to the active
hence, we will use the C2 nomenclature. Extracellularsite, thus explaining the interfacial activation of this
ligands that activate cPLA2 cause the phosphorylationimportant lipase.
of the catalytic domain on serines 505 and 727 (Lin et
al., 1993; Leslie, 1997), two residues that are conserved
Introduction across all species and are phosphorylated in multiple
cell types (de Carvalho et al., 1996; BoÈ rsch-Haubold et
Leukotrienes and prostaglandins are lipid mediators im- al., 1998). Although the mutation of Ser-505 to Ala is
portant in asthma, arthritis, and other inflammatory dis- known to block cPLA2 activation by members of the MAP
eases. Leukotrienes cause airway obstruction in asth- kinase family (Lin et al., 1993), the functional relevance of
matics through bronchoconstriction, increased mucus Ser-727 has not been reported.
secretion, and chemoattraction of inflammatory cells; Several lines of evidence suggested that cPLA2 may
prostaglandins potentiate pain and edema associated be a member of the a/b hydrolase family. These enzymes
possess a common core that consists of a well-con-with arthritis (O'Byrne, 1997; Simon et al., 1998). Cyto-
served mixed b sheet whose strands are interspersedsolic phospholipase A2 (cPLA2) cleaves phospholipid
by a helices and employ a catalytic triad similar to themembranes to release arachidonic acid, which in turn
one present in serine proteases (Schrag and Cygler,is metabolized to prostaglandins by the cyclooxygenase
1997). The catalytic mechanism of cPLA2 proceedspathway and to leukotrienes by the 5-lipoxygenase
through a serine-acyl intermediate (Reynolds et al.,pathway. Concomitant with the release of arachidonate,
1993; Trimble et al., 1993; Hanel and Gelb, 1995) usinglyso-platelet-activating factor (lyso-PAF) is formed, which
Ser-228 as the nucleophilic residue (Sharp et al., 1994;can then be acetylated to generate PAF, a molecule
Huang et al., 1996). This serine is present in a pentapep-also implicated in the pathophysiology of asthma and
tide sequence, G-L-S-G-S, which is similar to the classicarthritis (Venable et al., 1993; Tjoelker et al., 1995).
ªlipase motifº G-X-S-X-G (Schrag and Cygler, 1997)Although cPLA2 is a member of a diverse superfamily
found in a/b hydrolases. The catalytic serine of theseof phospholipase A2 enzymes (Dennis, 1997), numerous
enzymes is present in a tight turn between a b strandpieces of evidence have supported its central role in
and an a helix, termed the ªnucleophilic elbowº (seelipid mediator biosynthesis: cPLA2 is the only enzyme
review by Schrag and Cygler, 1997). This arrangementthat is highly selective for phospholipids containing ara-
forces the serine residue to adopt unusual main chainchidonic acid in the sn-2 position (Clark et al., 1991,
φ,c torsion angles and requires that the 12 and 22 side1995; Hanel and Gelb, 1993); activation of cPLA2 or its
chains be small to avoid steric clash, thus the prevalenceincreased expression has been linked with increased
of the G-X-S-X-G motif (Derewenda and Derewenda,leukotriene and prostaglandin synthesis (Lin et al.,
1991).1992a, 1992b, 1993); and following activation, cPLA2
In addition to Ser-228, Asp-549 was shown to be es-translocates to the nuclear membrane, where it is colo-
sential for cPLA2 activity. However, none of the 19 histi-calized with the cyclooxygenase and lipoxygenase that
dine residues were enzymatically relevant (Pickard etmetabolize arachidonate to prostaglandins and leuko-
al., 1996). A different residue, Arg-200, was shown to
be required for catalysis, suggesting that cPLA2 may* To whom correspondence should be addressed (e-mail: adessen@
genetics.com [A. D], wsomers@genetics.com [W. S. S.]). employ a novel mechanism.
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Table 1. Statistics for Data Collection, Phase Determination, and Refinement
Data Collection
Native Peak Inflection Descending Edge
Wavelength (AÊ ) l 5 1.20 l1 5 1.64902 l2 5 1.64963 l3 5 1.64834
Max. resolution (AÊ ) 2.5 3.4 3.3 3.2
Rsym (%)a 6.4 (30.0) 11.2 (41.5) 10.3 (37.1) 9.0 (38.6)
% completeness 93.3 (87.9) 99.6 (99.4) 99.7 (99.5) 99.6 (99.5)
Total reflections 271,686 195,666 213,851 233,142
Unique reflections 66,223 54,331b 59,265b 64,885b
,I/s(I). 18.2 (3.3) 9.9 (2.6) 12.3 (3.3) 13.3 (2.8)
f9 (e2)c 29.89 217.50 21.86
f″ (e2) 31.90 18.63 19.24
MAD Phasing
Resolution limits (AÊ ) 9.67 6.70 5.44 4.69 4.18 3.81 3.53 3.37 Overall
Phasing power d
l2 3.26 4.08 3.65 2.84 2.07 1.48 1.11 0.93 2.24
l1 isomorphous 1.20 1.15 1.05 0.83 0.75 0.68 0.63 0.53 0.83
l1 anomalous 3.25 4.26 3.89 3.18 2.37 1.70 1.30 1.21 2.59
l3 isomorphous 0.98 1.20 1.24 1.32 1.39 1.39 1.35 1.28 1.30
l3 anomalous 3.18 4.01 3.58 2.99 2.30 1.66 1.26 1.07 2.34
Mean FOMe 0.77 0.75 0.70 0.63 0.55 0.44 0.35 0.29 0.51
Model Refinement
Resolution (AÊ ) 12.0±2.5
R factor (%)f 22.9 Rfree (%) 29.8 ,B value. (AÊ 2) 47.7
Rms deviations from ideal geometry
Bonds (AÊ ) 0.016
Angles (8) 1.94
B values (AÊ 2) 6.7
a Rsym 5 S |Ih 2 ,Ih.|/SIh, where ,Ih. is the average intensity over symmetry equivalents. Numbers in parentheses reflect statistics for the
last shell.
b Friedel pairs separate.
c f9 and f99 reported values were refined by SHARP.
d Phasing power 5 S|FH|/S||FPHobs| 2 |FPHcalc||, where FH is the calculated heavy atom structure factor amplitude.
e Figure of merit 5 ,|SP(a)eia/S|P(a)|., where a is the phase and P(a) is the phase probability distribution.
f R 5 S||Fobs| 2 |Fcalc|/S|Fobs|, where Rfree is calculated for a randomly chosen 10% of reflections and R factor is calculated for the remaining
90% of reflections (F . 2.0) used for structure refinement.
Like both the 14 kDa secreted PLA2s and the lipases obtained at 188C using PEG 1000 as a precipitant and
employing standard vapor diffusion techniques. Singleof the a/b hydrolase family, cPLA2 preferentially cleaves
substrates presented at a membrane interface rather crystals grew within a few days to dimensions of up to
0.6 mm 3 0.5 mm 3 0.1 mm and diffracted to a minimumthan in monomeric form (Nalefski et al., 1994). This phe-
nomenon, known as interfacial activation, has been at- Bragg spacing of 2.5 AÊ . Crystals are of space group
P21212 (a 5 153.59 AÊ , b 5 95.49 AÊ , c 5 139.13 AÊ ), withtributed to both localized conformational changes in the
lipases of the a/b hydrolase family and, in the case two monomers (1498 residues) and 60% solvent per
asymmetric unit.of secreted PLA2s, more favorable presentation of the
substrate (Scott et al., 1990). To date, no experiments Attempts to prepare heavy atom±soaked crystals of
cPLA2 revealed that only gadolinium or terbium couldhave provided insight into cPLA2's 1500-fold preference
for substrate at an interface. generate isomorphous derivatives. Either lanthanide re-
Despite the key role of cPLA2 in inflammatory disease, placed a single Ca21 atom in the C2 domain, thus provid-
its three-dimensional structure remained unsolved, leav- ing a single heavy atom scatterer per 749 amino acid
ing numerous questions unanswered. Here, we report residues. In-house phasing information from these crys-
the X-ray crystal structure of human cPLA2 at 2.5 AÊ tals was not of high enough quality to produce an inter-
resolution. The structure provides insight into the origin pretable electron density map. This observation, added
of arachidonate selectivity and interfacial activation, to the fact that binding of most heavy atoms generated
clarifies the roles of Ser-228, Asp-549, and Arg-200, nonisomorphism between native and soaked crystals,
and reveals the interplay between the C2 and catalytic led to an effort to solve the structure of cPLA2 by multi-
domains. Unexpectedly, the structure is of a unique to- wavelength anomalous dispersion (MAD) phasing (Hen-
pology, distinct from that of the a/b hydrolase family. drickson, 1991).
Data at three different wavelengths around the Tb LIII
Results edge (see Table 1) were collected from a single Tb-
treated crystal. Experimental phases to 3.2 AÊ were sub-
sequently modified by solvent flattening and noncrys-The Structure of cPLA2 Was Solved by Employing
One Heavy Atom Scatterer Per 749 Residues tallographic symmetry averaging and extended to 2.5
AÊ . This procedure generated an electron density mapFull-length human cPLA2 was expressed in CHO cells
as described in Experimental Procedures. Crystals were of extraordinary quality (Figure 1) in which both domains
Crystal Structure of Human cPLA2
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Figure 1. Experimental Map Generated with
MAD Phases Obtained from Scattering of a
Single Tb Atom Per 749 Residues of cPLA2
Solvent flattening (60% solvent content) and
two-fold noncrystallographic symmetry aver-
aging were employed for map generation.
of each cPLA2 monomer could be clearly identified. The 434±456, however, are disordered (see Figure 5A), mak-
ing it impossible to accurately define the true size of thepresent model contains 1260 residues (between both
monomers) and 48 water molecules. basic patch. Nevertheless, it is noteworthy that similar
basic patches were seen in PI4 kinase and in different
species of secreted PLA2s (Rao et al., 1998). It is tempt-Molecular Structure
The cPLA2 monomer is a two-domain ellipsoidal struc- ing to suspect that the high-affinity binding of cPLA2 to
membranes made of phosphatidyl methanol (Hixon etture with dimensions of z100 AÊ 3 55 AÊ 3 45 AÊ (Figure
2A). The N-terminal domain (residues 16±138) is a b al., 1998) is mediated through this region.
sandwich of the C2 family (Nalefski and Falke, 1996),
connected by residues 139±143 to the catalytic domain, The N-Terminal C2 Domain
The structure of the C2 domain in full-length cPLA2 iswith which it forms very few protein±protein contacts.
The central core of the catalytic domain is composed very similar to those solved by NMR and X-ray crystal-
lography (Xu et al., 1998; Perisic et al., 1998), with minorof a 10-strand central b sheet with interspersed helices,
and its topology is unexpectedly distinct from that of differences. Briefly, it consists of eight antiparallel b
strands interconnected by six loops, folding into a bthe canonical a/b hydrolase fold. The cPLA2 monomers
present in the asymmetric unit are not perfectly superim- sandwich that fits the ªtype IIº topology for C2 domains
(Nalefski et al., 1994). Two Ca21 atoms, spaced 4 AÊposable due to flexibility of the interdomain loop; super-
position of the C2 domains leads to a 48±58 difference apart, are bound at one end of the C2 domain through a
constellation of Asp and Asn side chains and backbonebetween the two catalytic domains. The interdomain
loop has a slightly different conformation in each mono- carbonyl atoms on three distinct loops; the same atomic
arrangement has been observed in the C2 domainmer, and its residues display high temperature factors.
cPLA2 is a cytosolic protein that binds to its target solved by Perisic and coworkers (1998). The environ-
ment of the Ca21 atoms in full-length cPLA2, however,membrane through its C2 domain when intracellular lev-
els of Ca21 are raised (Clark et al., 1991). The domain does not display the same water molecules present in
the C2 structure solved by these authors. Instead, coor-arrangement of cPLA2 suggests how the active site is
oriented with respect to the cellular membrane. Figure dinated to calcium site 1 (defined in Perisic et al., 1998)
is a molecule of MES (2-[N-morpholino] ethanesulfonic2B is a surface diagram that highlights results of HSQC
studies performed on the C2 domain by Xu and cowork- acid) from the buffer employed in crystallization and
cryoprotection. In both cPLA2 monomers, the distanceers (1998). Residues that displayed N15/NH shifts upon
binding to dodecylphosphocholine micelles in these ex- between Ca21 1 and the closest MES sulfonate oxygen
atom is approximately 2.2 AÊ . In addition, the morpholinoperiments are highlighted in purple. It is clear that the
highlighted residues appear on the same face of the group is also in contact with the side chains of His-
62 and Tyr-96, which form a small hydrophobic niche.molecule as the active site. Consequently, if the C2
domain employs these residues to associate with a Although a crystallization artifact, the coordination of
Ca21 1 of cPLA2 to the sulfate group of MES could bephospholipid membrane, the catalytic domain is roughly
positioned to bind a phospholipid substrate in the active emulating the binding mode of the phosphate group of
a phospholipid molecule.site. The flexibility of the linker between the two domains
as well as the lack of major protein±protein interactions
between them suggests that a small rotation between The Novel Topology of the cPLA2 Fold
Distinguishes It from a/b Hydrolasesdomains can occur to optimize interactions with the
membrane. The catalytic domain of cPLA2 is composed of 14 b
strands and 13 a helices; its central core consists of aAs shown in the surface potential diagram in Figure
2C, a highly basic region extends from the active site 10-stranded central mixed b sheet surrounded by 9 a
helices with strands b4, b5, b10, b11, and b12 formingthrough a strip of positively charged residues on the b3
strand of the C2 domain (Arg-57 and Arg-59). Residues the most obvious portion of the sheet (see Figure 2A
Cell
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Figure 2. Ribbon and Surface Diagrams of
cPLA2
(A) Ribbon diagram of the cPLA2 monomer.
The C2 domain is shown in green, with the
two Ca21 atoms depicted in red. The ªcapº
structure of cPLA2 is colored purple. Mobile
loops with poor electron density are shown
as dots. The flexible linker between the C2
and catalytic domains is colored red. The po-
sitions of the four serine residues, which are
phosphorylated in cPLA2, are also shown. For
clarity, b9 and b10 have not been labeled;
b10 lies between b4 and b12. Figure prepared
with MOLSCRIPT (Kraulis, 1991) and RAST-
ER3D (Bacon and Anderson, 1988).
(B) GRASP surface diagram of cPLA2. Resi-
dues that presented N15/NH shifts upon in-
teraction with dodecylphosphocholine mi-
celles in NMR experiments by Xu et al. (1998)
are colored purple. The cPLA2 active cleft is
highlighted in red. Lid residues (413±457)
have been removed for clarity.
(C) Surface potential representation of cPLA2,
with regions with electrostatic potential ,23.5
kBT are red, while those .13.5 kBT are blue
(KB, Boltzmann constant; T, absolute temper-
ature). The lid residues (413±457) have been
removed for clarity, and neither calcium nor
MES was employed in the generation of the
potential. A highly basic patch is clearly visi-
ble on the membrane-binding region of the
molecule and also encompasses residues
57±61, which are located on the b3 strand of
the C2 domain. Figure prepared with GRASP
(Nicholls, 1992). All views are in the same ori-
entation, with the plasma membrane coming
from the direction of the eyes of the reader.
and the Richardson diagram in Figure 3B). The b sheet The first b strand in the cPLA2 core is b1, which follows
the flexible connection after the C2 domain. A loop con-has a superhelical twist with b6 and b11 lying approxi-
mately 908 to one another. For simplicity, the secondary taining one long helix makes the connection to b4, in
the central part of the fold. The following parallel belements of cPLA2 have been identified based on the
a/b hydrolase fold nomenclature presented by Schrag strand, b5, precedes the catalytic serine (228). The to-
pology of b5, helix C (colored pink in Figures 3A andand Cylger (1997), in which the catalytic serine is pre-
ceded by b5 and followed by helix C. 3B), and of their interconnecting loop is similar to that
Crystal Structure of Human cPLA2
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(b10, b11, and b12) are positioned as to complete the
central b sheet and are interspersed by helices G to J.
The a/b hydrolase fold is common to many esterases
and other hydrolytic enzymes (Derewenda and Dere-
wenda, 1991; Schrag and Cygler, 1997). Its Richardson
diagram (Figure 3A) consists of a central b sheet whose
order of b strands follows the sequence linearly (with
the exception of b3, which is often placed between b4
and b5). At first glance, the topology of cPLA2 appears
to be a circular permutation of the a/b hydrolase fold.
However, a careful comparison of Figures 3A and 3B
clearly reveals that only the region encompassing the
nucleophilic elbow is in fact directly comparable (b5 to
helix C; residues 222±238). Major distinctions include
the antiparallel nature of strands b6 to b9, the multiplicity
of helices between b5 and b6, and the absence of in-
tervening helices between strands of the latter part of
the cPLA2 a/b core.
Although the cap structure in cPLA2 (residues 370±
548) is part of the catalytic domain, it is not included in
the a/b core. cPLA2 displays 30% identity in its catalytic
domain with two other lipases, cPLA2s b and g (Un-
derwood et al., 1998; C. Song et al., unpublished data),
and their sequence comparisons (Figure 4) show that
homology is concentrated within the a/b core (yellow
elements) and b strand 9a and a helix Fa. Thus, the
central part of the cap is distinct among cPLA2 isoforms.
A comparison between the ribbon diagram of cPLA2 in
Figure 2A, in which the cap region is displayed in purple,
and the surface potential diagram in Figure 2C reveals
that the highly basic region hypothesized above as mak-
ing electrostatic contacts with membrane phospholipids
is in fact formed in large part by cap residues.
The cap region of cPLA2 also contains two of the three
most mobile regions of the entire structure, residues
433±456 and 500±536; the third region is the C terminus,
Figure 3. Richardson Diagrams of cPLA2 and the Canonical a/b Hy- residues 722±749. These amino acid stretches do not
drolase Fold have traceable electron density and are not included in
(A) Richardson representation of the canonical a/b hydrolase fold. the model (dotted lines in Figure 2A). Interestingly, it is
b strands are represented as arrows, while a helices are rectangles. these highly flexible regions of the cap that harbor threeSecondary structural element numbering is according to the review
of the four serine residues that become phosphorylatedby Schrag and Cygler (1997). Helix C, which immediately follows
upon agonist stimulation (437, 454, and 505). The rolethe ªnucleophilic elbow,º is colored pink.
(B) Richardson diagram of the cPLA2 fold. The naming scheme was of Ser-437 and Ser-454 is unclear, since they are not
devised so that the helix immediately following Ser-288 is helix C, conserved among different species. In contrast, Ser-
as in the canonical a/b hydrolase fold. The central core is colored 505 is conserved in cPLA2 from evolutionarily distinctyellow for a more facile comparison with the canonical a/b hydrolase
species (chicken, human, zebrafish, mouse, and rat),fold in (A). Elements composing the ªcapº are colored purple; loop
and its phosphorylation by MAP kinase is required forregions in red are highly mobile and do not present traceable elec-
tron density. Lid residues (see text) are represented primarily by maximal activation of cPLA2 (Lin, et al., 1993; Qiu et al.,
helix Fc. 1998). Ser-505, which in our crystals may be heteroge-
neously phosphorylated and is located in a highly flexi-
ble, solvent-exposed loop, makes no contacts either
with the body of the protein or other neighboring cPLA2seen in a/b hydrolases. This interconnecting loop is
monomers in the lattice. The fourth site of cPLA2 phos-termed the ªnucleophilic elbow.º Three more a helices,
interwoven by loops, provide the connection between phorylation, Ser-727, is at the C terminus of the struc-
ture. Although this site is conserved among species, itsthis region and the further four b strands of this part of
the fold (b6±b9). functional relevance is not yet known (Qiu et al., 1998).
A recent report describing dramatic activation ofAfter b9 there is a major divergence from the central
a/b core. The cPLA2 sequence at this point forms the cPLA2 by phosphatidylinositol 4,5-bisphosphate led to
the suggestion that cPLA2 may contain a pleckstrin ho-region shown in purple in Figures 2A and 3B. This 180-
residue patch forms a catalytic domain ªcap.º Asp-549, mology domain (Mosior et al., 1998). Analysis of our
structure reveals no region with similarity to a pleckstrinthe catalytic partner of Ser-228, immediately follows
b9d. Following the cap structure, the last three b strands homology domain.
Cell
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Figure 4. Primary Structure Alignment of
cPLA2 a, b, and g
Secondary structural elements observed in
the X-ray crystal structure of cPLA2 a are indi-
cated below the sequences and are color
coded as components of the cap region (pur-
ple) or main fold (yellow). Lines represent ar-
eas of turns or loops. Residues identified with
dotted lines do not display traceable electron
density. The asterisk identifies residues lining
the active site or present in the lid.
A Deep Active Site Funnel Is Partially helix (Fc; Figure 3B) and a short turn. Residues 408±412,
which lead into the lid region, display large temperatureCovered by a Solvent-Accessible Lid
The most remarkable feature of the cPLA2 structure is factors, and residues 434±456 do not possess traceable
electron density. These observations suggest that boththe active site funnel, which penetrates one-third of the
way into the catalytic domain to reveal Ser-228 and of these regions are highly mobile and could be envi-
sioned as ªlid hinges.º Given this flexibility, it is likelyAsp-549 placed at the bottom of a deep, narrow cleft.
Although wide at the top, the funnel narrows to an ap- that the lid is in a different conformation when substrate
is bound. Notably, the visible region of the lid is amphi-proximate diameter of 7 AÊ at the mouth of the active
site cleft visible in Figure 5A. The funnel is lined with pathic; its solvent-exposed face is formed primarily by
polar residues (T416, E418, E419, E420, and N423), whilehydrophobic residues (blue in Figure 5A) and forms a
cradle into which fatty acyl moieties of membrane phos- the inner side is lined with hydrophobic amino acids
(M417, L421, and I424).pholipid substrates may bind. The 8 AÊ distance between
the Og of Ser-228 and the top of the active site cleft is X-ray crystallography has yielded multiple examples
of lipases that exist in both ªclosed lidº and ªopen lidºenough to accommodate up to the first cis double bond
of a bound arachidonyl substrate, even in the most ex- forms, the latter crystallized in the presence of substrate
or inhibitors (Cygler and Schrag, 1997). Lipases thattended conformation of the molecule.
Attempts to model a diacylphospholipid molecule in exist in both forms are known to undergo a phenomenon
termed interfacial activation, in which catalytic activitythe active site cleft of cPLA2 demonstrated that the acyl
ester bond cannot be positioned in the vicinity of Ser- is greater in the presence of micellar rather than mono-
meric substrates. Likewise, cPLA2 undergoes such acti-228 without the fatty acid chains clashing with residues
located directly above it (Figure 5A). These residues, vation. It is possible that movement of the cPLA2 lid
exposes both the active site and a greater hydrophobicwhich partially block access to the active site, appear
to be part of a ªlidº composed of amino acids 413±457. surface, which could be stabilized by interacting with
the membrane.The lid folds into a loop region, followed by a small
Crystal Structure of Human cPLA2
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Figure 5. Catalytic Domain and Active Site of cPLA2
(A) Surface diagram showing the catalytic domain of cPLA2 covered by the lid residues. Ser-228 is shown at the bottom of the funnel. The
continuation of the sequence not visible in experimental maps is represented by red dots and is proposed to be involved in the formation of
a lid hinge. Residues for which only the backbone atoms are visible in electron density maps are represented as alanines. Exposed surfaces
of all hydrophobic residues have been colored blue, and that of Arg-200 has been colored red. The figure was prepared with GRASP (Nicholls,
1992).
(B) Close-up of the active site of cPLA2. The two residues involved directly in catalysis are colored green. Arg-200 and the loop harboring Gly
residues 197 and 198 are shown in yellow. A single water molecule visible in the experimental maps hydrogen bonds with Asp-549 and a
carbonyl oxygen from Thr-330. Figure generated with MOLSCRIPT and RASTER3D.
Catalysis by cPLA2 Proceeds via a Mechanism present in serine proteases, where the histidine residue
is spatially positioned between the serine and the aspar-Distinct from that of Other Acyl Hydrolases
Acyl hydrolysis by a/b hydrolases is performed by a tate. Histidine, activated by aspartate, abstracts the ser-
ine proton during its nucleophilic attack on the substratecatalytic triad (Ser-His-Asp/Glu) analogous to the one
Cell
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guanidinium group of Arg-200 is not part of the catalytic
triad, its role remains uncertain. Its location near the
mouth of the active site cleft appropriately positions it
to interact with the phosphate moiety of the substrate.
However, Pickard et al. (1996) reported that the activity
of cPLA2 toward a non±phosphate-containing substrate
(arachidonic acid ester of 7-hydroxycoumarin) was also
greatly reduced by mutagenesis of Arg-200, thus sug-
gesting that this residue may serve multiple purposes.
It is noteworthy that Arg-200 is located on the same
loop as Gly-197/198 of the oxyanion hole and its side
chain hydrogen bonds with Thr-680 and with the back-
bone carbonyl oxygen atoms of Phe-576 and Phe-678.
The lack of these hydrogen bonds in the Arg-200 Lys
mutant reported by Pickard and coworkers (1996) could
be responsible for subtle alterations in the conformation
of the oxyanion hole loop with dramatic consequences
on activity.
Based on our crystal structure and other biochemical
experiments showing evidence of a serine-acyl interme-Figure 6. Transition-State Complex Proposed for cPLA2, Involving
diate in cPLA2 catalysis, we propose a mechanism forthe Attack of Ser-228 on the sn-2 Position of the Substrate
cPLA2 (see Figure 6). After calcium-dependent mem-Phosphate atoms are shown in black; residues involved in catalysis
brane translocation, an individual substrate moleculeare depicted in green. Gly-197 and 198 are suggested as being part
can diffuse into and bind in the narrow cleft of the activeof the oxyanion hole, while Arg-200 stabilizes the phosphate moiety
of the head group. AA, arachidonic acid; HG, head group; C18, site such that its sn-2 ester bond is close to Ser-228.
octadecyl group. The phosphate moiety of the head group is stabilized
by the Arg-200 side chain, and both fatty acyl chains can
be directed back toward the top of the cleft. Followingester bond. Although a similar mechanism was antici-
formation of the enzyme±substrate complex, Asp-549pated for cPLA2, site-directed mutagenesis (Sharp et al.,
activates Ser-228 by abstracting a proton during its nu-1994; Pickard et al., 1996) identified Ser-228 and Asp-
cleophilic attack at the sn-2 ester. An oxyanion hole549 as essential for catalysis, but none of the 19 histidine
formed by the backbone amide groups of Gly-197 andresidues were required for activity. Surprisingly, muta-
Gly-198 polarizes the sn-2 ester and stabilizes the transi-genesis of Arg-200 to either lysine or alanine had a
tion state of the developing tetrahedral intermediate.dramatic effect. These observations suggested several
The serine-acyl intermediate is generated upon collapsenovel catalytic mechanisms, including one in which Arg-
of the tetrahedral intermediate with transfer of a proton200 replaced histidine in the catalytic triad (Pickard et
from Asp-549 to the leaving lysophospholipid. Hydroly-al., 1996).
sis of the acyl intermediate by water then occurs throughHowever, instead of the expected triad, the X-ray crys-
an analogous mechanism. cPLA2 may then either disso-tal structure of cPLA2 clearly reveals an active site dyad
ciate from the membrane interface or bind another phos-in which the Og atom of Ser-228 is only 2.9 AÊ from Od2
pholipid substrate, repeating the cycle.of Asp-549. The guanidinium group of Arg-200 is 9 AÊ
Although a nucleophilic serine in the absence of aaway from Ser-228 Og, and all histidines are outside of
catalytic triad is unusual, it is observed in both class Aa 10 AÊ radius. All polar interactions within a 3.5 AÊ range
TEM-1 b-lactamase (Matagne et al., 1998) and penicillinof either Asp-549 or Ser-228 are made by backbone
acylase (Duggleby et al., 1995). In the case of b-lactam-groups or a lone water molecule positioned 3.2 AÊ away
ase, Ser-70 is activated by Glu-166 with the participationfrom Asp-549 Od1 (Figure 5B). Although Asn-555 lines
of a bridging water molecule. In the catalytic mechanismthe active site funnel, its Nd2 atom is approximately 6
of penicillin acylase, the N-terminal serine is activatedAÊ away from either residue.
by its own a-amino group, again through a bridgingIn proteases and lipases, certain amide backbone
water. Thus, cPLA2 is a third distinct example of anatoms within the cleft are often positioned to stabilize
acylase using a nucleophilic serine without a completethe negative charge that develops upon nucleophilic
catalytic triad.attack by serine and are thus termed the ªoxyanion
hole.º Analysis of the electron density map in the region
of Ser-228 showed that the peptide bonds of residues Discussion
Gly-197 and Gly-198 are in an approximate cis configu-
ration. In this orientation, both amide protons are appro- Since leukotrienes, prostaglandins, and PAF play signifi-
cant roles in the pathophysiology of major diseasespriately positioned to stabilize a developing oxyanion.
In addition, the backbone amide group of Gly-229, lo- (Bonventre et al, 1997; Uozumi et al., 1997), it is impor-
tant to understand the three-dimensional structure ofcated in the nucleophilic elbow, may also be part of the
oxyanion hole. Consequently, this region appears to be cPLA2, an enzyme central in their biosynthesis. The
cPLA2 fold clearly shows that the enzyme consists ofwell designed to stabilize the transition state generated
by nucleophilic attack by Ser-228. two distinct, independently folded domains. This result
was not unexpected based on earlier work in which theAlthough it is clear from the crystal structure that the
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C2 and catalytic domains were fully functional when The selectivity for arachidonyl-containing phospholip-
ids is a distinguishing feature of cPLA2 (Hanel and Gelb,expressed independently (Nalefski et al., 1994, 1998).
However, the sparsity of contacts between the domains 1993; Clark et al., 1995). This selectivity can originate
either in a substrate-driven or an enzyme-driven sce-was surprising. The only residue in the catalytic domain
of cPLA2 observed to directly contact C2 is Lys-371, nario. In the first scenario, the polyunsaturation of the
arachidonyl phospholipids ensures looser packing andwhich forms a salt bridge with Asp-55. In addition, the
high temperature factors and distinct conformation of thus greater exposure of the scissile sn-2 ester bond
located at the membrane±water interface. In this case,the interdomain linker in the two monomers in the cPLA2
asymmetric unit are a further indication of flexibility be- one would expect the catalytic machinery of cPLA2 to
be on the surface of the enzyme, where it could acttween the domains.
Although C2 domains are commonly observed in sig- without extracting the lipid from the bilayer. This situa-
tion would be analogous to the one presented by thenaling molecules, the C2 domains of PLCd1 and now
cPLA2 are the first to be reported in the context of a flattened kinase domain of Type IIb phosphatidylinositol
phosphate kinase, where the enzyme phosphorylatescatalytic domain (Essen et al., 1996; Grobler et al., 1996).
In contrast to cPLA2, extensive hydrophobic contacts phosphatidylinositol in situ (Rao et al., 1998). In contrast,
in the enzyme-driven scenario, the phospholipid is ex-exist between the PLCd1 domains, indicating a fixed
orientation. In both PLCd1 and cPLA2, the calcium bind- tracted from the membrane such that the cis double
bonds of the sn-2 fatty acid are in direct contact withing loops of the C2 domains are thought to interact with
the membrane surface (Grobler et al., 1996; Nalefski the active site. The structure reported in this work clearly
demonstrates that arachidonic acid selectivity is en-and Falke, 1998; Perisic et al., 1998; Xu et al., 1998).
Superposition of the C2 domains of both PLCd1 and zyme driven, since the active site serine lies in a cleft
so deep that at least the 5-cis double bond remains incPLA2 reveal that their catalytic sites are both facing
the membrane surface. However, they are rotated by the cleft even in the fatty acid's most extended confor-
mation. This particular double bond has been shown toapproximately 108±208 with respect to one another, sug-
gesting that a slight reorientation of the cPLA2 domains be the most relevant for cPLA2 arachidonate selectivity
(Hanel and Gelb, 1995).may be critical for appropriate membrane positioning. It
is noteworthy that Ser-505, which is essential for optimal The level of identity between cPLA2 a and g allows us
to confidently identify the residues in cPLA2 g that lineactivity in cells, is located near the interdomain linker
region. Although far from certain, it is possible that phos- the active site. This analysis shows that only two resi-
dues differ within the cleft. Although these changes mayphorylation of Ser-505 favors an optimal orientation be-
tween the C2 and catalytic domains of cPLA2. be responsible for the much lower arachidonyl selectiv-
ity shown by cPLA2 g (Underwood et al., 1998), there isThe detailed comparison of the structure of cPLA2 and
the classic a/b hydrolase fold clearly argues that cPLA2 no homology between lid residues of cPLA2 a and g. It
will be informative to mutate the residues that are dis-contains a novel topology. However, as noted earlier, the
b hairpin containing the active site serine is structurally tinct between a and g cPLA2s in order to determine
residues responsible for selectivity.analogous to the ªnucleophilic elbowº of the a/b hy-
drolase fold. It should be noted that serines present in The conformation of cPLA2 shown in this structure
must represent the ªclosedº form of the enzyme, sinceG-X-S-X-G motifs in proteases do not share this same
conformation (Derewenda and Derewenda, 1991). A the fatty acyl chains of a substrate modeled into the
active site cleft clash with the lid residues. We expectBlast search (Altschul et al., 1997) of the cPLA2 catalytic
domain shows a short region of homology with phos- that, upon membrane binding, the lid must move to
allow active site access, consistent with the interfacialpholipase B's and lysophospholipases that include Gly-
197/198 of the oxyanion hole Arg-200 and the cPLA2 activation noted for cPLA2 upon binding to the mem-
brane interface (Nalefski et al., 1994). This phenomenonlipase motif, which contains Ser-228. The high homol-
ogy in the short region is also consistent with the geno- of lid movement and interfacial activation has been
noted for numerous lipases (Cygler and Schrag, 1997).mic structure, since these residues are encoded by a
single exon (Bonventre et al., 1997; Uozumi et al., 1997). Lid movement in many of these enzymes increases the
exposed hydrophobic surface. The amphipathic natureTwo mechanisms could be proposed for cPLA2 em-
ploying Ser-228 and Asp-549 for catalysis. In one mech- of the lid in cPLA2 suggests that the enzyme can change
from a soluble, closed conformation to an open, moreanism, Asp-549 could act as an acid catalyst, hydrogen
bonding to the carbonyl of the sn-2 ester without directly hydrophobic form stabilized by membrane binding.
Although we cannot comment on the conformation ofinteracting with Ser-228. However, the crystal structure
clearly shows that Asp-549 is ideally positioned to act the lid or hinge regions in the open form, it is clear from
Figure 5A that the semicircular rim of the active siteas a general base, directly activating Ser-228. Thus, we
propose the transition state shown in Figure 6. Although funnel is raised (approximately 7 AÊ ) above the mouth of
the active site cleft. If this rim were to rest on the mem-it is difficult to compare the efficiency of this catalytic
dyad to the traditional Ser-His-Asp triad of the a/b hy- brane surface, it would require the substrate to traverse
solvent-filled space before reaching the cleft. Conse-drolases and serine proteases, it is the activation energy
required to reach the transition state that is important quently, we propose that the rim residues are at least
partially imbedded in the membrane interface, consis-in catalysis. Thus, any energetic deficiencies inherent
to the dyad may be offset by very strong hydrogen bonds tent with the prevalence of hydrophobic residues at this
location. The charged residues that lie between the ac-between the developing negative charge on the carbonyl
oxygen and the oxyanion hole (Cleland and Kreevoy, tive site cleft and the rim may interact with phospholipid
head groups. The extent of penetration proposed also1994).
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(BruÈ nger et al., 1990) (12±2.5 AÊ ) after the Rfree had dropped belowplaces the basic patch obvious in Figure 2C proximal
32% (BruÈ nger, 1992a). Subsequent model-building stages were per-to the membrane surface. This membrane-binding model
formed with the aid of omit maps generated through maximum-is consistent with the increased affinity of cPLA2 for likelihood refinement as implemented in BUSTER (Bricogne, 1993).
anionic lipids (Hixon et al., 1998) as well as its inhibition Refinement also included a uniform bulk solvent correction (Bsol 5
by sphingomyelin, whose rigid structure would disfavor 23.8 AÊ 2; ksol 5 0.305 e2/AÊ 3) and the application of noncrystallo-
graphic symmetric restraints. All diffraction data with F . 2.0 (88.6%interface penetration (Leslie and Channon, 1990).
of all reflections) were used throughout the refinement except for a
10% randomly selected test set, which was used for calculation ofExperimental Procedures
Rfree. Fo-Fc maps were used to locate water molecules, which were
placed at sites that displayed densities .3.0 s and exhibited reason-Protein Production, Crystallization, and Data Collection
able protein±solvent hydrogen bonding distances without stericFull-length human cPLA2 (residues 1±749) was expressed in E5-
conflict. The final model contains 1260 residues (molecule A: 13±433,CHO cells as described in Lin et al. (1992b). The cell pellet was
457±498, and 540±721) and 48 water molecules; it exhibits goodlysed in pH 9.0 buffer, and cPLA2 in the supernatant was precipitated
stereochemistry, with an average bond length and bond angle devia-with (NH4)2SO4 (30%±45%). Heparin sepharose, Q sepharose, and
tion from ideal geometry of 0.016 AÊ and 1.948, respectively. 98.1%size exclusion chromatography steps yielded protein samples suit-
of all residues are in most favorable and additionally allowed regionsable for crystallization experiments. Analysis by capillary electro-
of a Ramachandran plot, with 0.4% in disallowed regions. The overallphoresis indicated that the protein was heterogeneously phosphory-
free R value is 29.8%, and the R factor is 22.9% using diffractionlated. A typical yield from a 100 g pellet was 15±25 mg of pure cPLA2
data between 12 and 2.5 AÊ (Table 1).(M. Stahl et al., unpublished data).
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